| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,442 |
1,990 |
$243K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
945 |
821 |
$108K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,044 |
469 |
$55K |
| 36415 |
Collection of venous blood by venipuncture |
3,960 |
3,534 |
$30K |
| 85027 |
|
751 |
705 |
$18K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
381 |
360 |
$15K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
312 |
287 |
$11K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
33 |
25 |
$8K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
581 |
345 |
$5K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
145 |
136 |
$3K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
48 |
43 |
$3K |
| 80053 |
Comprehensive metabolic panel |
40 |
38 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
25 |
24 |
$2K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
26 |
25 |
$1K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
56 |
29 |
$1K |
| 80061 |
Lipid panel |
28 |
28 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
117 |
113 |
$857.95 |
| 0001A |
|
64 |
63 |
$809.87 |
| 0002A |
|
47 |
46 |
$690.09 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
28 |
28 |
$643.10 |
| G2024 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source |
27 |
14 |
$587.00 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
15 |
13 |
$481.72 |
| 0072A |
|
12 |
12 |
$216.69 |
| 0124A |
|
15 |
15 |
$173.28 |
| 83605 |
|
13 |
12 |
$165.48 |
| 0004A |
|
20 |
19 |
$164.70 |
| J3490 |
Unclassified drugs |
28 |
16 |
$160.39 |
| 87081 |
|
15 |
15 |
$109.02 |
| A9270 |
Non-covered item or service |
37 |
12 |
$3.16 |